Through new diagnostic methods, integrated approaches and innovative management solutions, patients no longer have to live with discomfort. Here are three major ways the GI field is evolving to better care for patients today. The post Thinking with Our Gut: How the Management of GI Conditions is Evolving appeared first on MedCity News.
KFF Health News editor-at-large for public health Céline Gounder discussed the possibility of a bird flu pandemic on WAMU’s “1A” on Feb. 20. Gounder also discussed the potential of an off-label drug being studied to help some autistic kids improve their ability to speak on CBS News’ “CBS Evening News” on Feb. 17. Click here…
EndPoints notes that the Most Favored Nation Executive Order has led some large pharmaceutical firms to make two changes: (i) start charging Europeans the same price as the US, and (ii) start selling more products direct to consumer (a.k.a. ‘pharm to table‘) AbbVie, Novartis and Boehringer Ingelheim each joined their peers in making price-related concessions…
The longer we delay, the further we shift costs from polluters to patients — and to every taxpayer who funds Medicare, Medicaid and community hospitals. Environmental stewardship and human health are inseparable; regulating microplastics is preventive medicine on a national scale. The post Microplastics Are in Our Blood — Why Aren’t Federal Regulators Acting? appeared…
Two Chairs, which offers hybrid behavioral health care, expanded its presence from three states to 22 states. This expansion gives millions of people access to therapy services, as Two Chairs’ services are now available to 75% of the U.S. population. The post Two Chairs Expands Mental Health Services to 19 More States appeared first on…
By KIM BELLARD I feel much about synthetic biology as I do AI: I don’t really understand it from a technical point of view, but I sure am excited about its potential. Sometimes they even overlap, as I’ll discuss later. But I’ll start with some recent developments with bioplastics, a topic I have somehow never…
Under the Health IT Alignment Policy, ASTP and HHS partners have identified billions of dollars that impact health IT across HHS programs and activities; ONC and HHS inform
Eli Lilly drug Ebglyss is now FDA-approved for atopic dermatitis, an inflammatory skin disorder also known as eczema. The biologic drug came from Lilly’s $1.1 billion acquisition of Dermira in 2020. The post New Eli Lilly Eczema Drug Brings Competition and Dosing Edge Versus Sanofi, LEO Pharma Meds appeared first on MedCity News.
To better understand how states are preparing for Medicaid work requirements, states were asked to discuss anticipated challenges to implementing work requirements by the end of 2026, including related system changes and data matching.